转录因子SPI1驱动免疫抑制性CD45+红系祖细胞改善类风湿关节炎
本研究探讨CD45+红系祖细胞(CD45+ EPCs)在类风湿关节炎(RA)中的作用。在RA患者和胶原诱导性关节炎(CIA)小鼠中,CD45+ EPCs扩增并与疾病活动度正相关、与血红蛋白负相关。机制上,SPI1上调并结合TGFB1启动子驱动TGF-β产生,通过CCR2-CCL2轴招募后调节巨噬细胞极化,从而减轻炎症。
要点
- RA中CD45+ EPCs扩增,与疾病活动度正相关、与血红蛋白负相关。
- SPI1驱动TGF-β产生,CD45+ EPCs经CCR2-CCL2轴招募并调节巨噬细胞极化。
- 过继转移CD45+ EPCs改善CIA小鼠关节炎,提示治疗潜力。
核心结论
- CD45+ EPCs是RA中一种新的、SPI1驱动的免疫抑制性细胞群,通过SPI1/TGF-β信号调节巨噬细胞减轻炎症。
研究设计与样本
- 分析RA患者和CIA小鼠中CD45+ EPCs频率,采用转录组学、功能研究和机制实验(Transwell、双荧光素酶报告基因、染色质免疫沉淀后定量PCR),并在RA滑膜类器官和CIA小鼠脾切除/过继转移中测试治疗潜力。
主要发现
- CD45+ EPCs在RA循环和CIA小鼠脾脏中扩增,与疾病活动度正相关、与血红蛋白负相关。
- RA来源的CD45+ EPCs显示增强的增殖和TGF-β/活性氧产生,高表达CCR2使其易被巨噬细胞来源的CCL2招募。
- 在RA滑膜类器官中,CD45+ EPCs通过TGF-β抑制生长和炎症,而类器官条件培养基通过CCL2促进其迁移。
- 招募的CD45+ EPCs抑制M1并促进M2样巨噬细胞极化。
- 转录因子SPI1在RA CD45+ EPCs中上调,结合TGFB1启动子并驱动TGF-β产生;体内脾切除加重CIA,而过继转移CD45+ EPCs改善关节炎。
临床怎么用
- SPI1/TGF-β信号轴和CCR2-CCL2轴可能成为RA的潜在治疗靶点。
- CD45+ EPCs的过继转移在CIA模型中显示治疗作用,提示细胞治疗可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Anaemia is common in rheumatoid arthritis (RA), but the role of erythroid-lineage cells is unclear. We investigated the function of CD45+ erythroid progenitor cells (CD45+ EPCs) in RA. METHODS: We analysed CD45+ EPC frequency in patients with RA and mice with collagen-induced arthritis (CIA). Transcriptomics, functional studies and mechanistic assays (Transwell and dual-luciferase reporter assays, chromatin immunoprecipitation followed by quantitative PCR) were used. Therapeutic potential was tested in RA synovial organoids and via splenectomy/adoptive transfer in mice with CIA. RESULTS: CD45+ EPCs were expanded in RA circulation and CIA mouse spleens, correlating positively with disease activity and negatively with haemoglobin. They displayed an immunosuppressive transcriptome, enriched for transforming growth factor (TGF)-β and chemokine signalling. RA-derived CD45+ EPCs showed enhanced proliferation and TGF-β/reactive oxygen species production. High C-C Motif Chemokine Receptor 2 (CCR2) expression made them susceptible to recruitment by macrophage-derived C-C Motif Chemokine Ligand 2 (CCL2). In RA synovial organoids, CD45+ EPCs suppressed growth and inflammation via TGF-β, while organoid-conditioned media promoted their migration via CCL2. Recruited CD45+ EPCs suppressed M1 and promoted M2-like macrophage polarisation. The transcription factor SPI1 was upregulated in RA CD45+ EPCs, bound the TGFB1 promoter and drove TGF-β production. In vivo, splenectomy worsened CIA, whereas adoptive transfer of CD45+ EPCs ameliorated arthritis. CONCLUSION: We identify CD45+ EPCs as a novel, SPI1-driven immunosuppressive population in RA. Recruited via the CCR2-CCL2 axis, they attenuate inflammation by modulating macrophages through SPI1/TGF-β signalling, revealing a new immunoregulatory axis and potential therapeutic targets.
引用
- Zhu WH, Wang ML, Meng X, et al. Transcription factor SPI1 drives immunosuppressive CD45+ erythroid progenitor cells to ameliorate rheumatoid arthritis. RMD Open. 2026. PMID: 41720597. doi:10.1136/rmdopen-2025-006472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。